Session

NAFLD: Risk, prevention and therapy (Posters)

GLOBAL PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS
GLOBAL PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS

NAFLD: Risk, prevention and therapy (Posters)  et al.

A MULTICENTER CLINICAL STUDY ON SARS-COV2 PANDEMIC CONFINEMENT: A FORCED IN VIVO TEST OF SHORT-TERM LIFESTYLE CHANGES AND THE INFLUENCE ON METABOLIC- (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION
A MULTICENTER CLINICAL STUDY ON SARS-COV2 PANDEMIC CONFINEMENT: A FORCED IN VIVO TEST OF SHORT-TERM LIFESTYLE CHANGES AND THE INFLUENCE ON METABOLIC- (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION

NAFLD: Risk, prevention and therapy (Posters)  et al.

EFFECTS OF INTERMITTENT FASTING ON METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE ARE TRANSMISSIBLE THROUGH FECAL TRANSPLANTS
EFFECTS OF INTERMITTENT FASTING ON METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE ARE TRANSMISSIBLE THROUGH FECAL TRANSPLANTS

NAFLD: Risk, prevention and therapy (Posters)  et al.

INFLUENCE OF PROARA2 POLYMORPHISMS OF THE PPARG2 GENE AND TRP64ARG OF THE ADRB3 GENE ON THE EFFECTIVENESS OF NON-DRUG TREATMENT OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
INFLUENCE OF PROARA2 POLYMORPHISMS OF THE PPARG2 GENE AND TRP64ARG OF THE ADRB3 GENE ON THE EFFECTIVENESS OF NON-DRUG TREATMENT OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

NAFLD: Risk, prevention and therapy (Posters)  et al.

COMPARATIVE EFFICACY OF PHARMACOLOGIC THERAPIES FOR LIVER STEATOSIS AND FIBROSIS IN PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE BASED ON MAGNETIC RESONANCE IMAGING BIOMARKERS: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
COMPARATIVE EFFICACY OF PHARMACOLOGIC THERAPIES FOR LIVER STEATOSIS AND FIBROSIS IN PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE BASED ON MAGNETIC RESONANCE IMAGING BIOMARKERS: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

NAFLD: Risk, prevention and therapy (Posters)  et al.

IMPACT OF INTERMITTENT FASTING ON LABORATORY, RADIOLOGICAL, AND ANTHROPOMETRIC PARAMETERS IN NAFLD PATIENTS
IMPACT OF INTERMITTENT FASTING ON LABORATORY, RADIOLOGICAL, AND ANTHROPOMETRIC PARAMETERS IN NAFLD PATIENTS

NAFLD: Risk, prevention and therapy (Posters)  et al.

GLOBAL PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS
GLOBAL PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS

NAFLD: Risk, prevention and therapy (Posters)  et al.

COMPARATIVE EFFICACY OF PHARMACOLOGIC THERAPIES FOR LIVER STEATOSIS AND FIBROSIS IN PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE BASED ON MAGNETIC RESONANCE IMAGING BIOMARKERS: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
COMPARATIVE EFFICACY OF PHARMACOLOGIC THERAPIES FOR LIVER STEATOSIS AND FIBROSIS IN PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE BASED ON MAGNETIC RESONANCE IMAGING BIOMARKERS: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

A MULTICENTER CLINICAL STUDY ON SARS-COV2 PANDEMIC CONFINEMENT: A FORCED IN VIVO TEST OF SHORT-TERM LIFESTYLE CHANGES AND THE INFLUENCE ON METABOLIC- (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION
A MULTICENTER CLINICAL STUDY ON SARS-COV2 PANDEMIC CONFINEMENT: A FORCED IN VIVO TEST OF SHORT-TERM LIFESTYLE CHANGES AND THE INFLUENCE ON METABOLIC- (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION

EFFECTS OF INTERMITTENT FASTING ON METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE ARE TRANSMISSIBLE THROUGH FECAL TRANSPLANTS
EFFECTS OF INTERMITTENT FASTING ON METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE ARE TRANSMISSIBLE THROUGH FECAL TRANSPLANTS

INFLUENCE OF PROARA2 POLYMORPHISMS OF THE PPARG2 GENE AND TRP64ARG OF THE ADRB3 GENE ON THE EFFECTIVENESS OF NON-DRUG TREATMENT OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
INFLUENCE OF PROARA2 POLYMORPHISMS OF THE PPARG2 GENE AND TRP64ARG OF THE ADRB3 GENE ON THE EFFECTIVENESS OF NON-DRUG TREATMENT OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

IMPACT OF INTERMITTENT FASTING ON LABORATORY, RADIOLOGICAL, AND ANTHROPOMETRIC PARAMETERS IN NAFLD PATIENTS
IMPACT OF INTERMITTENT FASTING ON LABORATORY, RADIOLOGICAL, AND ANTHROPOMETRIC PARAMETERS IN NAFLD PATIENTS

Item 1 - 12 / 12
1